bioAffinity Technologies, Inc. (BIAF) Stock Statistics & Valuation Metrics

bioAffinity Technologies, Inc. has a market cap or net worth of $2.88M. The enterprise value is $3.25.

bioAffinity Technologies, Inc. has 592,373 shares outstanding. The number of shares has decreased by -2.65% in one year.

bioAffinity Technologies, Inc.’s return on equity (ROE) is -2.05 and return on invested capital (ROIC) is -125.29%.

The current PE Ratio of bioAffinity Technologies, Inc. is ―. bioAffinity Technologies, Inc.’s PEG ratio is 0.00222.

In the last 12 months, bioAffinity Technologies, Inc. had revenue of 6.16M and earned -14.91M in profits. Earnings per share was -129.90.

In the last 12 months, operating cash flow was -11.47M and capital expenditures -31.41K, giving a free cash flow of -11.50M billion.

bioAffinity Technologies, Inc. pays an annual dividend of ―, resulting in a dividend yield of ―

bioAffinity Technologies, Inc. upcoming earnings date is Nov 18, 2026, Before Open (Confirmed).

bioAffinity Technologies, Inc. as a current ratio of 2.60, with Debt / Equity ratio of 38.08%

In the past 12 months, bioAffinity Technologies, Inc. has paid 44.04K in taxes.

bioAffinity Technologies, Inc. EV to EBITDA ratio is 0.23, with an EV/FCF ratio of 0.35.

bioAffinity Technologies, Inc. has $2.43M in cash and marketable securities with $1.44M in debt, giving a net cash position of $994.71K billion.

Gross margin is -39.57%, with operating margin of -171.58%, and net profit margin of -241.96%.

The average price target for bioAffinity Technologies, Inc. is ―, which is 11.43% higher than the current price. The consensus rating is ―